December 3, 2020 marked a historic milestone when the World Health Organization (WHO) made an announcement, endorsing the therapeutic properties of CBD in medicinal use. This decision, taken after a vote, has changed the global perception of one of the most widely used cannabinoids in the world, recognizing it as beneficial.
From Gorilla Grillz, we have decided to share and highlight this significant news.
WHO statement on the use of CBD:
“There is preliminary evidence that CBD may be a useful treatment for medical conditions […] epilepsy, anxiety, inflammatory diseases, pain, nausea, etc…”
The WHO Expert Committee on Drug Dependence, at a key meeting held in Geneva, Switzerland, between 6 and 10 November 2017, focused on examining the therapeutic properties of CBD, as well as its potential side effects and the risk of addiction. As a result of these deliberations, the body has issued a detailed report summarizing the opinions of cannabidiol experts.
The document not only underscores the efficacy of CBD in the treatment of epilepsy and other pathologies, but also emphasizes that CBD is not included in the schedules of controlled substances by the United Nations Drug Conventions of 1961, 1971, and 1988. This implies that the UN does not classify this cannabinoid as a drug in the traditional sense.
The publication of this report by the WHO represents a significant advance in the recognition and research of medical cannabis, opening paths for future studies on CBD’s healing capabilities.
Summary of CBD Analysis by Experts
Here we summarize the conclusions reached by the WHO commission of experts:
CBD is characterized by being a non-addictive and safe substance for health: Research carried out on animals indicates the absence of development of tolerance to CBD, as well as the lack of physical dependence. In fact, an opposite effect has been observed when it comes to dopamine, as high doses of CBD do not promote an increase in its release. In studies of intracranial stimulation in mice, excessive use of CBD showed no adverse side effects. Human clinical trials reveal that CBD generates a dependence comparable to placebo, and that it does not induce significant psychoactive or cardiovascular effects on its own. In addition, it is concluded that the abuse of cannabidiol does not lead to negative effects.
CBD does not represent a cause for social concern: The second aspect addressed in the WHO report highlights the absence of social alarm linked to the use of CBD, as well as the lack of incidents related to this substance.
CBD as a potential therapeutic agent: The report highlights research that evidences the efficacy of CBD in treating epilepsy, as well as presenting a list of other medical conditions in which CBD could be beneficial.
Substance implications: Based on the findings presented, the WHO report determines that CBD has no psychoactive effects, does not induce addiction and shows considerable potential in therapeutic applications. For this reason, the agency suggests the need to deepen research related to this substance.
Exploring studies and recommendations
The assessment by the WHO has ushered in an era of research, both clinical and preclinical, that suggests CBD’s key role in combating conditions such as epilepsy, anxiety, persistent pain, and inflammatory processes. This analysis invites us to investigate whether there are other benefits of CBD that the WHO has highlighted.
This summary provides an overview of the contents, but for more detailed information on the specific benefits that the WHO identifies in CBD, it would be advisable to review additional sources or the original WHO report.
Bibliography and Digital Sources
- Access to the report in PDF: https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_63Reconvened/Press_statement_CND_2_December.pdf
-
WHO statement: https://www.who.int/news/item/04-12-2020-un-commission-on-narcotic-drugs-reclassifies-cannabis-to-recognize-its-therapeutic-uses
SOUTHERN PHARMA SPAIN S.L will not assume any liability arising from the use by third parties of the content of the website and may exercise all civil or criminal actions that correspond to it in the event of infringement of these rights by the user. It is absolutely forbidden to use the website or any of its elements for illicit purposes. The benefits and properties of cbd that could be read on the website www.gorillagrillz.com are in no way attributed to the products sold on the website. CBD products are not medicines and should not replace treatments with them. What you can read on our website are not official medical claims but references to preclinical studies. If you have any questions, you can consult with a professional health personnel. We remind you that in Spain CBD products are for topical use. All products have THC<0.2% analyses in accordance with Royal Decree 1729/1999.
| Pablo Ruiz Professional copywriter. |
